BUSINESS

How to Play Rising Food Prices

By Steve McDonald, Investment Analyst Host of The Oxford Club’s Market Wake-Up Call Saturday, January 29, 2011Editor’s Note: In this edition of the Investment U Weekend Update, Steve tackles… Food Inflation – and How to Cash in on it… Demand for Silver Coins Goes Crazy… Coming Soon to a Market Near You… a Rally: The Sectors Primed to Run Higher The”Slap in the Face” Award* * * * * * * * * *Food inflation in the United States is up around 3% over the past year – 1.5 times the rate of inflation. What’s more, Andrew Wolf of BBT Capital says a 5% jump is not out of the question and could cause real sticker shock in grocery prices. Already, dairy is up 5.5%, while fruit and vegetable prices have risen by 3.5%.In fact, CNBC did a comparison of costs for five basic foods – meat, dairy, vegetables, bread and consumables – and found that prices have jumped by as much as 22% to 27%, depending on where you live. If you haven’t seen the big moves yet in your local market, it’s because for the most part, stores have been absorbing the costs.What you will notice is that the size of packaged goods will be smaller, while the cost has remained the same. That’s a tricky price increase you’re not supposed to notice, but still a price increase.How to Cash in on Food InflationFood commodity traders Jim Bower (of Bower Trading) and Shawn Hacket (of Hacket Trading) say there’s one food that hasn’t seen the big price increases of wheat and corn: Rice. According to both of them, it will run higher. With current rice production at 30 to 40-year lows, this will add fire to the pricing when demand picks up this year, in order to catch up to the production shortfall.While commenting that grains were the big winners last year, Bower and Hacket also both say to look for cattle, dairy cattle, butter and milk prices to rise in 2011. Also, high grains prices will make farmland costs for planting sky-high. But they say food store stocks are not the best way to play this move. Other ways to profit form this inflation is to use exchange-traded notes (ETNs) and exchange-traded funds (ETFs) that focus on food groups like cattle and hogs, for example. Make sure you research them thoroughly before jumping in.The Silver Coin CrazeNicholas Colas, Convergas’ Chief Market Strategist, says the demand for silver coins has tripled in the last 18 months. Why? Because gold is too expensive for the average guy , in addition to concerns about the dollar and the euro, which are driving people to an alternative currency – silver coins. And silver coins are also a good hedge against inflation.Colas says this is a return the days in the late 1970s when silver ran to around US$52 per ounce. Today, we essentially we have a fixed supply of silver, set against an increasing supply of money, which means the foundation is set for a large price run-up. He likes gold and real estate… if you can afford gold and can wait out the real estate market recovery.Coming to a Market Near You Soon… a Rally!Steve East of Height Analytics says we’re likely to see a market pullback in the next few months, but it will merely be a temporary glitch in what he calls a big run in 2011. His prediction for the S&P 500: 1,500 points – over 20% higher. That forecast is based on corporate profits running at all-time highs, with corporate earnings the only V-shaped recovery in the world.East says the market is currently at about 80% to 83% of its full value, so there’s plenty of room to run. The market multiples have to increase. East likes energy, industrials and materials, all of which have lagged so far.The”Slap in the Face” AwardToday’s award goes to the folks who created the sales and marketing for cell phones. Their effort is a true modern wonder. My current cellphone is about six or seven years old. Many of my younger friends laugh at it, but it works and costs me nothing. It’s fine for me. It has a camera that I’ve never used and it’s always worked, which is more than I can say for other phones I own.But they should see the first cellphone I owned – an absolute monster (picture Gordon Gekko’s in the movie”Wall Street”) and was only six or seven years older than the phone I have now. The advances in technology have been ridiculous, but at the time, it was the cat’s meow!My point is this: I won’t buy a so-called smartphone because as soon as I do, it will be outdated and I’ll still look foolish to younger folks. I still won’t use any more of its amazing applications than I do with this one. I hate the fact that I’m supposed to be available 24/7 on these things and texting just seems redundant. I’m not that interested in knowing what my friends are doing all the time. I don’t care.But the job that the marketing and sales players have done to convince buyers that they must have the newest and best phones has been one of the best I’ve ever seen and my hat is off to Verizon (NYSE: VZ), Apple (Nasdaq: AAPL) and AT&T (NYSE: T). They’ve created a market out of thin air and demand that’s beyond comparison.But I don’t want all this phone technology. I find it excessive. It reminds of what my father asked me when I installed an eight-track tape player under the dash of the car I had in college. He said;”Don’t you have a radio in that thing?” I guess nothing ever really changes.Good investing,Steve McDonaldReprinted with permission of the publisher. The above story can be read on the website www.investmentU.com. The direct link is: LINK]Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.Views expressed are not FNArena's (see our disclaimer).FN Arena is building the future of financial news reporting at www.fnarena.com . Our daily news reports can be trialed at no cost and with no obligations. Simply sign up and get a feel for what we are trying to achieve.Subscribers and trialists should read our terms and conditions, available on the website.All material published by FN Arena is the copyright of the publisher, unless otherwise stated. Reproduction in whole or in part is not permitted without written permission of the publisher.

World Market Overview Report 31/1/2011

Fears over unrest in Egypt sent U.S. stocks reeling Friday to their biggest one-day decline in months and put an end to the market's eight-week win streak, as investors sought safety while oil prices surged.

Daily forex forecast - 31/1/2011

The Australian Dollar fell back below 99 cents at the start of Asian session on Friday and consolidated around 0.9890 for the remainder of onshore trade.
More news

Online retailers attract more customers and investors

The changing landscape of the retail industry pushes into forefront the increasing attractiveness of online operators, which industry players said have been enticing both consumers and investors attentions for their value offerings and return promises.

The Emerging Market Healthcare Trend That Nobody is Talking About

By Marc Lichtenfeld, Healthcare Specialist - Wednesday, January 26, 2011: Issue #1436Very few Wall Street analysts are calling for the healthcare or biotech sectors to be among the top performers this year. And I love it. Why? Two reasons… The contrarian in me knows that this usually spells a big opportunity. Because Wall Street analysts have a horrendous track record for picking stocks. In fact, The Wall Street Journal has noted that analysts’ least favorite stocks usually outperform their favorite ones by a wide margin.For what it’s worth, Wall Street expects overall biotech sector revenue to climb by a fairly ho-hum 8% this year. Whatever.For starters, I suspect that figure is too conservative. And regardless of what Wall Street thinks, it’s no secret that I’m a big biotech fan, anyway. And at the moment, it’s easy to see why. As I’ve mentioned, there are several big healthcare trends that bode very well for biotech companies… not the least of which is the big pharma “patent cliff.” Given the drug makers’ shallow pipelines, biotech companies should be attractive acquisition candidates in the near future…For example, consider just a few companies with new breakthrough drugs that are expected to become blockbusters (among nearly a dozen others): Dendreon’s (Nasdaq: DNDN ) prostate cancer drug, Provenge. Vertex Pharmaceuticals’ (Nasdaq: VRTX ) hepatitis therapy, Telaprevir. The drug is expected to receive FDA approval in May and could generate as much as $4 billion in annual sales. Human Genome Sciences’ (Nasdaq: HGSI ) treatment for lupus.But these “hotshot” analysts are also overlooking what I think will be the biggest growth area for biotech in the coming months…The Emerging Market Drug ExplosionI’m talking about emerging markets, such as Brazil, India, China, Russia, Mexico and South Korea. Right off the bat, places like China, India and South America could see overall drug revenue growth rates as high as 15% per year, versus just 1% to 3% in the United States and Europe. Drug sales in “pharmerging” markets are expected to hit $400 billion between 2006 and 2020, according to IMS – growth of more than 600%. And it’s easy to see why… More People… More Drugs… More SalesJust like in the United States, emerging market populations are aging. For example, more than 200 million Chinese will be over 65 by 2020. And as people get older, they suffer more illnesses and chronic conditions – and therefore need more medicines and procedures. Additionally, as the middle classes boom in emerging markets, unhealthy western-style diets become more popular, which leads to more diseases like diabetes. Already, more than 30% of Chinese adults are considered overweight – a figure that’s expected to rise to 50% in the coming years.According to the International Diabetes Foundation, by 2025 there will be 80 million diabetics in India and 42 million in China. That compares to a forecast of 33 million in the United States by 2030. Pfizer (NYSE: PFE ) recently paid $200 million to partner with Biocon, in order to obtain worldwide rights to the Indian biotech company’s insulin products. But zero in on the emerging markets’ healthcare growth trend a bit more and you’ll find that a large chunk of the expansion will come from the onset of “biosimilars” – i.e. generic copies of biotech drugs…Why the Healthcare Heavyweights Are Embracing Emerging MarketsAt the moment, there are no biosimilars in the United States and very few in Europe. But don’t expect this to last long. In some cases, the big biotech and drug companies are even developing biosimilars of their own drugs because they know that their high-priced branded drugs won’t fly in emerging markets.For example, Amgen (Nasdaq: AMGN ) and Biogen Idec (Nasdaq: BIIB ) are examining ways to create biosimilars. Merck (NYSE: MRK ) and Parexel International (Nasdaq: PRXL ) are working together on a similar initiative. However, some emerging market companies are trying to beat the Americans and Europeans to the punch. In South Korea, for example, Samsung is investing 500 billion won (roughly $446 million) into biosimilars.It’s easy to see why biotech companies are pouring money into programs outside of the United States and Europe, too. Emerging markets represent a nascent market for these firms. And while very few have a meaningful presence, that’s starting to change. For example, Celgene (Nasdaq: CELG ), which has operations in various emerging markets, should get approval for Revlimid in Russia and Turkey later this year.Biotech: A Great Investment Now… and for a Long Time to ComeIn short, the biotech sector should enjoy a strong year, based on new drug approvals and the growing popularity of therapies that are often more effective and less toxic than traditional pharmaceuticals. But the move into emerging markets will be attractive for healthcare and biotech companies, due to the massive growth opportunities within them. And looking past 2011, the emerging market healthcare wave should be one that investors can ride for a decade or more.Good investing, Marc LichtenfeldReprinted with permission of the publisher. The above story can be read on the website www.investmentU.com. The direct link is: http://www.investmentu.com/2011/January/emerging-market-healthcare-trends.htmlNothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.All views expressed are Investment U's, not FNArena's (see our disclaimer).FN Arena is building the future of financial news reporting at www.fnarena.com . Our daily news reports can be trialed at no cost and with no obligations. Simply sign up and get a feel for what we are trying to achieve.Subscribers and trialists should read our terms and conditions, available on the website.All material published by FN Arena is the copyright of the publisher, unless otherwise stated. Reproduction in whole or in part is not permitted without written permission of the publisher.

Australia’s consumer confidence declines

Fourth quarter (December 2010) results from Nielsen's Global Online Consumer Survey show that the Australian consumer has slightly lost their confidence, as a conservative drop of three points takes the Consumer Confidence Index score to 112 points (this compared to September's high of 115 (Chart 1)). But the latest score is still a good five points higher than the one recorded this time last year (107), and is still a positive result for Australia.

Lenovo, NEC forms Japan’s largest PC group

Leading Japanese and Chinese electronics firms NEC Corporation and Lenovo on Thursday announced a strategic partnership to create the largest PC group in Japan. The agreement aligns NEC, Japan's number one PC company, with Lenovo, the fastest growing top-five PC maker in the world. The new joint venture gives both Lenovo and NEC a unique opportunity to grow their commercial and consumer PC businesses in Japan, the third largest PC market in the world, through a stronger market position, enhan...

Daily forex forecast - 28/1/2011

The Australian Dollar fell from just shy of parity yesterday to 0.9950 as news hit the wires that Prime Minister Julia Gillard announced that the cost of the recent funding in Queensland would take 0.5% off of Australia's GDP and that the rebuilding cost would be in the region of AUD5.6 billion.

World Market Overview Report 28/1/2011

Most Asian markets ended higher Thursday, with Tokyo stocks getting a boost from a bullish earnings view and a slightly weaker yen, but declines in Chinese property developers weighed on shares in China and Hong Kong.

The Overnight Report: 12,000 Rejected, Again

By Rudi Filapek-VandyckDJIA up 4.39 to 11,989, the S&P500 up 2.91 to 1,299.54 and the Nasdaq up 15.78 to 2,755.There was plenty to get excited about for both bulls and bears last night and as a result financial markets moved rather erraticly, torn between good news and bad news. First signal with a bearish undertone came from Standard and Poor’s as the rating agency announced it cut Japan’s credit rating for the first time in nine years to AA- from AA. By doing so, S&P once again highlighted concerns about Japan’s fiscal sustainability in the longer run. The downgrade suggests Japan needs to make moves to rein in its debt, or at the very least put a plan in place to do so.In addition, economic data in the US further added to the day's disappointments. Durable goods orders fell 2.5% in December, below market expectations of a 1.5% gain, after aircraft orders declined by USD5bn. Initial jobless claims spiked 51K to 454K last week, but it goes without saying adverse weather provided an unquantifiable impact. For once, better news came from the US housing market with pending home sales printing above market expectations, rising 2.0%. Economists point out the index has rebounded sharply following the expiration of the homebuyer tax credit, and is back to levels that were occurring before its introduction.Corporate results in the US were once again mixed. Investors seemed to like the releases by Caterpillar and Qualcomm, but they showed disappointment post releases from AT&T and Procter & Gamble. After the closing bell shares in online retailer Amazon are under selling pressure post the release of Q4 results. The Dow Industrials traded above 12,000 for the second session in a row but in the end it had to retreat -again- below the magical psychological target. The S&P500 similarly missed the opportunity to (finally) close above 1300.Later today, all eyes will be firmly focused on the initial estimate of Q4 GDP data. The market is expecting the US economy finished calendar 2010 with an annualised growth rate of 3.5%.In Europe, mixed corporate results kept a lid on overall investor optimism. The German DAX closed 0.4% higher at 7156, the FTSE 100 fell 0.1% to 5965 and the Euro Stoxx 50 rose 0.7% to 2990. Keeping momentum positive on the old continent was the release of the Euro-zone Business climate index (Jan) which revealed a jump to 1.58 from an upwardly revised 1.38, pointing to outright European economic acceleration.FX markets experienced some genuine turmoil as the Japanese Yen turned south on news of the Japanese rating downgrade. The Aussie dollar was knocked around a few times, but ultimately saw buying support kicking in. AUD/USD opens in Asian trade on Friday morning at .9923, AUD/EUR opens at .7225, AUD/GBP opens at .6229, AUD/NZD opens at 1.2833 and AUD/JPY opens at 82.18.The Euro lifted to US$1.3755 from US$1.3640 over European and US trade and was near US$1.3725 in late US trade.Crude oil took its cue from weaker than anticipated economic data. The WTI futures contract for March fell 2.0% to USD85.61 per barrel. Spot gold equally had another challenging session. Spot gold dropped 2.5% to USD1312 per ounce overnight, its lowest level in over three months.Base metals, however, ticked higher following the previous day's rebound, with copper adding 2.1% to USD9523 per tonne on the LME, despite the mixed US data and despite expected seasonal slowdown in Chinese demand ahead of next week's Lunar New Year holiday. Recent outperformer tin added 1.2% to a new record high on continued tightening in supplies, while lead (+2.2%), aluminium (+2%), nickel (+0.8%) and zinc (+0.3%) were also all stronger.Agricultural commodities were mixed. Corn declined 1.1% after US exports of the grain disappointed expectations last week, and rain in Argentina boosted crop prospects, while wheat fell 1.2% but remained near its 2-year high. But sugar rose 3.2% on signs of rising demand in the EU and Russia. Soybeans increased 1%, and palm oil rose 0.4%.US treasury prices rose on Thursday (yields lower) after a successful sale of US$29 billion of seven-year notes. The Federal Reserve bought US$5.79bn of Treasuries maturing in the next 2-3 years. US 2yr yields fell by 4pts to 0.59% and US 10yr yields fell by 2pts to 3.39%.Today in Australia investors will zoom in on the Treasurer’s speech (around 1pm Brisbane time; 2pm Melb/ Sydney time) when he will flesh out the economic and fiscal impacts of the floods. Some commentators believe the floods, combined with the Gillard government's responses to it, are partially responsible for AUD weakness this month.SPI futures are indicating another subdued opening should be expected for the Australian share market today. SPI futures are currently indicating a gain of 12 points at the opening bell. However, the SPI has been far too optimistic whole week and why would it be any different today?[Note: All paying members at FNArena are being reminded they can set an email alert specifically for The Overnight Report. Go to Portfolio and Alerts in the Cockpit and tick the box in front of The Overnight Report. You will receive an email alert every time a new Overnight Report has been published on the website.]FN Arena is building the future of financial news reporting at www.fnarena.com . Our daily news reports can be trialed at no cost and with no obligations. Simply sign up and get a feel for what we are trying to achieve.Subscribers and trialists should read our terms and conditions, available on the website.All material published by FN Arena is the copyright of the publisher, unless otherwise stated. Reproduction in whole or in part is not permitted without written permission of the publisher.

Inflation: Down, But Not Out

Thanks to the strong dollar and shy consumers, plus the growing price war between Coles and Woolies, Australian inflation surprised on the downside in the December quarter.The headline rate for the CPI showed a 0.4% rise in the quarter, down from the 0.7% in the September quarter and well under the confident expectations from market economists for a 0.7% rise (and higher from a couple of forecasters).That was despite the expected sharp jump in fruit (up 15.5%) and vegetables (up 11.1%)in the quarter, an increase that is likely to be repeated to some extent this quarter because of the floods. They drove food prices up by 2.2% in the quarter, which was the biggest rise among all the groups in the CPI survey.The annual headline rate was 2.7% down on the 2.8% (restated) for the year to September.The underlying rate used by the Reserve Bank fell to the lowest level in a decade, and yet many in the markets remained unconvinced and were busy forecasting more price doom and gloom this quarter, after getting it wrong in the December quarter.That would normally raise the prospect of a rate cut in coming months, but the floods and the underlying price pressures from the resource boom will see the RBA sit pat for as long as possibleThe impact of the stronger dollar can be seen in the

The Fed: Sits on Rates, Says Recovery Continuing

The US Federal Reserve has again sat on its hands and not moved interest rates at its first meeting of 2011 in Washington. "The Committee will maintain the target range for the federal funds rate at 0 to 1/4 percent and continues to anticipate that economic conditions, including low rates of resource utilization, subdued inflation trends, and stable inflation expectations, are likely to warrant exceptionally low levels for the federal funds rate for an extended period," the Fed said in its statement after the two day meeting.Wall Street eased after the statement came out as many investors had been looking for a more upbeat statement.That wording is the same as previous statements, which disappointed some commentators who believe the recent spate of better economic news could see the Fed giving an indication of a possible resumption of rate rises.Rates were cut to their current record lows in December 2008 and it has been the continuing high unemployment which has kept the Fed from lifting rates and trying a second round of quantitative easing which seems to have sparked a rebound in share prices and commodities, but not in interest rates which have risen, rather than fallen.But the Fed again said the economic recovery was "continuing" which was the same expression in the December meeting statement."Information received since the Federal Open Market Committee met in December confirms that the economic recovery is continuing, though at a rate that has been insufficient to bring about a significant improvement in labor market conditions."Growth in household spending picked up late last year, but remains constrained by high unemployment, modest income growth, lower housing wealth, and tight credit."Business spending on equipment and software is rising, while investment in nonresidential structures is still weak."Employers remain reluctant to add to payrolls. The housing sector continues to be depressed."Although commodity prices have risen, longer-term inflation expectations have remained stable, and measures of underlying inflation have been trending downward."Fed chief Ben Bernanke will discuss the outlook at the National Press Club on February 3.He is also due to testify before Congress on monetary policy later next month.So more of the same of what we have been reading from the Fed for more than a wear.

NSW households turning away from credit cards

NSW households have turned their back on credit cards, slashing card debt by 20 per cent and trimming the number of cards owned. And, it was all done in the pre-Christmas period – traditionally a time of big card spending.

Top suburbs for rental returns

As more people delay buying houses and opt to rent, rates for residential rentals are expected to climb when demand overtakes supply.

ANZ: Home prices to stabilize

ANZ Bank is predicting that home prices will stabilize this year and remain flat to an average of $550,000 as a consequence of expected rising interest rates.

Pages